Specifically designed for the repair and treatment of poor quality, compromised bone; eg osteoporotic or pathologic.
The IlluminOss system utilizes a light curable polymer contained within an expandable balloon catheter to create a patient conforming intramedullary implant for bone stabilization.
The revolutionary procedure is made through a small minimally invasive surgical approach, providing patients and clinicians with a fast, patient specific method of orthopedic bone stabilization.
The Company currently markets it’s products in the EU under a CE mark and in the USA under FDA clearance.
Founded in 2007, IlluminOss is headquartered in East Providence, RI and funded by Tekla Capital, Life Science Partners, SR One, Pappas Ventures and Slater Technology Fund.